Trials / Completed
CompletedNCT00824226
Magnesium Treatment in Hypoparathyroidism
Effect of Magnesium Treatment on Plasma Calcium in Hypoparathyroid Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of Tartu · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study hypothesis: supplementary magnesium may influence the blood calcium level in treated hypoparathyroid patients. Patients will be treated with supplementary magnesium (350 mg/day) for 3 weeks. Calcium and other relevant blood parameters will be measured before the treatment, at the end of treatment and 2 weeks after stopping treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | magnesium | magnesium 350 mg tablets once a day for 3 weeks |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2009-01-16
- Last updated
- 2011-08-29
Locations
1 site across 1 country: Estonia
Source: ClinicalTrials.gov record NCT00824226. Inclusion in this directory is not an endorsement.